Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 138

1.

In vitro cytogenetic assessment and comparison of vildagliptin and sitagliptin.

Börçek Kasurka C, Elbistan M, Atmaca A, Atlı Şekeroğlu Z.

Cytotechnology. 2019 Sep 25. doi: 10.1007/s10616-019-00345-y. [Epub ahead of print]

PMID:
31555935
2.

Complete blood count and penile colour doppler ultrasonography findings in erectile dysfunction: Is there a relationship?

Gok B, Hamidi N, Koc E, Cakici OU, Asil E, Atmaca AF.

Andrologia. 2019 Oct;51(9):e13365. doi: 10.1111/and.13365. Epub 2019 Jul 4.

PMID:
31273827
3.

Distribution of psychogenic and vascular impotence in a tertiary health-care center's cohort: A retrospective study using penile Doppler imaging.

Gok B, Hamidi N, Cakici OU, Koc E, Kamaci D, Asil E, Keske M, Ozcan AN, Atmaca AF.

Rev Int Androl. 2019 Jul 1. pii: S1698-031X(19)30040-8. doi: 10.1016/j.androl.2019.01.002. [Epub ahead of print]

PMID:
31272908
4.

Efficiency of inferior petrosal sinus sampling in the diagnosis of Cushing's disease and comparison with magnetic resonance imaging.

Bekci T, Belet U, Soylu AI, Uzunkaya F, Ozturk M, Atmaca A.

North Clin Istanb. 2018 Aug 7;6(1):53-58. doi: 10.14744/nci.2018.83584. eCollection 2019.

5.

Diagnosis and Conservative Management of Ureteral Orifice Injury During Robotic Prostatectomy for a Large Prostate with a Prominent Median Lobe.

Bedir F, Keske M, Demirdogen SO, Kocaturk H, Atmaca AF, Canda AE.

J Endourol Case Rep. 2019 May 30;5(2):39-41. doi: 10.1089/cren.2018.0109. eCollection 2019.

6.

Randomized Phase II Trial of Seribantumab in Combination with Erlotinib in Patients with EGFR Wild-Type Non-Small Cell Lung Cancer.

Sequist LV, Gray JE, Harb WA, Lopez-Chavez A, Doebele RC, Modiano MR, Jackman DM, Baggstrom MQ, Atmaca A, Felip E, Provencio M, Cobo M, Adiwijaya B, Kuesters G, Kamoun WS, Andreas K, Pipas JM, Santillana S, Cho BC, Park K, Shepherd FA.

Oncologist. 2019 Aug;24(8):1095-1102. doi: 10.1634/theoncologist.2018-0695. Epub 2019 Apr 11.

PMID:
30975923
7.

Robotic Radical Cystectomy with Intracorporeal Studer Pouch Formation for Bladder Cancer: Experience in Ninety-Eight Cases.

Gok B, Atmaca AF, Canda AE, Asil E, Koc E, Ardicoglu A, Balbay MD.

J Endourol. 2019 May;33(5):375-382. doi: 10.1089/end.2019.0036. Epub 2019 Mar 30.

PMID:
30838878
8.

Robotic radical prostatectomy in 93 cases: Outcomes of the first ERUS robotic urology curriculum trained surgeon in Turkey.

Bedir F, Keske M, Demirdöğen ŞO, Kocatürk H, Koç E, Canda AE, Atmaca AF.

Turk J Urol. 2019 Feb 4. doi: 10.5152/tud.2019.24444. [Epub ahead of print]

9.

Tumor Mutational Burden and Efficacy of Nivolumab Monotherapy and in Combination with Ipilimumab in Small-Cell Lung Cancer.

Hellmann MD, Callahan MK, Awad MM, Calvo E, Ascierto PA, Atmaca A, Rizvi NA, Hirsch FR, Selvaggi G, Szustakowski JD, Sasson A, Golhar R, Vitazka P, Chang H, Geese WJ, Antonia SJ.

Cancer Cell. 2019 Feb 11;35(2):329. doi: 10.1016/j.ccell.2019.01.011. No abstract available.

PMID:
30753829
10.

Does Type 2 Diabetes Mellitus Have an Impact on Postoperative Early, Mid-Term and Late-Term Urinary Continence After Robot-Assisted Radical Prostatectomy?

Cakmak S, Canda AE, Ener K, Atmaca AF, Altinova S, Balbay MD.

J Endourol. 2019 Mar;33(3):201-206. doi: 10.1089/end.2018.0822. Epub 2019 Feb 13.

PMID:
30648427
11.

Third-Line Nivolumab Monotherapy in Recurrent SCLC: CheckMate 032.

Ready N, Farago AF, de Braud F, Atmaca A, Hellmann MD, Schneider JG, Spigel DR, Moreno V, Chau I, Hann CL, Eder JP, Steele NL, Pieters A, Fairchild J, Antonia SJ.

J Thorac Oncol. 2019 Feb;14(2):237-244. doi: 10.1016/j.jtho.2018.10.003. Epub 2018 Oct 10.

12.
13.

Does extent of prostate-specific antigen fluctuation can predict Gleason score upgrading in low-risk prostate cancer patients?

Hamidi N, Atmaca AF, Canda AE, Keske M, Ardıçoğlu A.

Turk J Urol. 2018 Aug 31:1-7. doi: 10.5152/tud.2018.41017. [Epub ahead of print]

PMID:
30183609
14.

Does Presence of a Median Lobe Affect Perioperative Complications, Oncological Outcomes and Urinary Continence Following Robotic-assisted Radical Prostatectomy?

Hamidi N, Atmaca AF, Canda AE, Keske M, Gok B, Koc E, Asil E, Ardicoglu A.

Urol J. 2018 Sep 26;15(5):248-255. doi: 10.22037/uj.v0i0.4276.

15.

Testis-sparing surgery: Experience in 13 patients with oncological and functional outcomes.

Keske M, Canda AE, Atmaca AF, Cakici OU, Arslan ME, Kamaci D, Balbay MD.

Can Urol Assoc J. 2019 Mar;13(3):E83-E88. doi: 10.5489/cuaj.5379. Epub 2018 Aug 30.

16.

Prognostic significance of the programmed death ligand 1 expression in clear cell renal cell carcinoma and correlation with the tumor microenvironment and hypoxia-inducible factor expression.

Tatli Dogan H, Kiran M, Bilgin B, Kiliçarslan A, Sendur MAN, Yalçin B, Ardiçoglu A, Atmaca AF, Gumuskaya B.

Diagn Pathol. 2018 Aug 25;13(1):60. doi: 10.1186/s13000-018-0742-8.

17.

Concurrent Repair of Inguinal Hernias with Mesh Application During Transperitoneal Robotic-assisted Radical Prostatectomy: Is it Safe.

Atmaca AF, Hamidi N, Canda AE, Keske M, Ardicoglu A.

Urol J. 2018 Nov 17;15(6):381-386. doi: 10.22037/uj.v0i0.4158.

18.

Management of ureteric duplications identified during robotic cystectomy and intracorporeal urinary diversion.

Koç E, Atmaca AF, Asil E, Gok B, Canda AE, Balbay MD.

Minerva Urol Nefrol. 2018 Oct;70(5):534-537. doi: 10.23736/S0393-2249.18.03136-3. Epub 2018 Jul 3.

PMID:
29969001
19.

Tumor Mutational Burden and Efficacy of Nivolumab Monotherapy and in Combination with Ipilimumab in Small-Cell Lung Cancer.

Hellmann MD, Callahan MK, Awad MM, Calvo E, Ascierto PA, Atmaca A, Rizvi NA, Hirsch FR, Selvaggi G, Szustakowski JD, Sasson A, Golhar R, Vitazka P, Chang H, Geese WJ, Antonia SJ.

Cancer Cell. 2018 May 14;33(5):853-861.e4. doi: 10.1016/j.ccell.2018.04.001. Epub 2018 May 3. Erratum in: Cancer Cell. 2019 Feb 11;35(2):329.

20.

The effect of corticosteroid on postoperative early pain, renal colic and total analgesic consumption after uncomplicated and unstented ureteroscopy: a matched-pair analysis.

Hamidi N, Ozturk E, Yikilmaz TN, Atmaca AF, Basar H.

World J Urol. 2018 Jun;36(6):979-984. doi: 10.1007/s00345-018-2210-1. Epub 2018 Feb 2.

PMID:
29396787
21.

Robotic management of a duplicated ureter during intracoporeal urinary diversion following robotic cystectomy.

Canda AE, Asil E, Koc E, Aldemir M, Ardicoglu A, Atmaca AF.

Cent European J Urol. 2017;70(3):321-322. doi: 10.5173/ceju.2017.1421. Epub 2017 Aug 3. No abstract available.

22.

Out-of-Reference Range Thyroid-Stimulating Hormone Levels in Levothyroxine-Treated Primary Hypothyroid Patients: A Multicenter Observational Study.

Yavuz DG, Yazıcı D, Keskin L, Atmaca A, Sancak S, Saraç F, Şahin İ, Dikbaş O, Hekimsoy Z, Yalın S, Uygur M, Yılmaz M, Yirmibeşcik S, Asmaz Ö.

Front Endocrinol (Lausanne). 2017 Sep 12;8:215. doi: 10.3389/fendo.2017.00215. eCollection 2017.

23.

A giant pararectal cyst successfully treated by robotic surgery.

Canda AE, Asil E, Keske M, Bedir F, Atmaca AF.

J Robot Surg. 2018 Jun;12(2):365-367. doi: 10.1007/s11701-017-0716-y. Epub 2017 Jun 2.

PMID:
28577283
24.

A Large Posteriorly Located Prostatic Mass Lesion Challenging the Robotic Surgeon: Prostate Leiomyoma.

Keske M, Canda AE, Atmaca AF, Bedir F, Gecit I, Ardicoglu A, Aydogdu OB, Agackiran Y, Ocal BG.

J Endourol Case Rep. 2017 May 1;3(1):61-63. doi: 10.1089/cren.2017.0033. eCollection 2017.

25.

Effect of bisphosphonate as an adjunct treatment for chronic periodontitis on gingival crevicuar fluid levels of nuclear factor-κB ligand (RANKL) and osteoprotegerin in postmenopausal osteoporosis.

Özden FO, Sakallioğlu EE, Demir E, Bilgici B, Tunçel ÖK, Gökosmanoğlu F, Atmaca A.

J Oral Sci. 2017;59(1):147-155. doi: 10.2334/josnusd.16-0241.

26.

Is testis-sparing surgery safe in small testicular masses? Results of a multicentre study.

Keske M, Canda AE, Yalcin S, Kilicarslan A, Kibar Y, Tuygun C, Onder E, Atmaca AF, Yildirim A, Ozkanli SS, Kandemir O, Kargi T, Sar M, Tugcu V, Resorlu B, Aslan Y, Sarikaya S, Boylu U, Cicek AF, Basar H, Tuncel A, Balbay MD.

Can Urol Assoc J. 2017 Mar-Apr;11(3-4):E100-E104. doi: 10.5489/cuaj.4016. Epub 2017 Mar 16.

27.

The effects of zoledronic acid treatment on depression and quality of life in women with postmenopausal osteoporosis: A clinical trial study.

Gokosmanoglu F, Varim C, Atmaca A, Atmaca MH, Colak R.

J Res Med Sci. 2016 Nov 7;21:112. doi: 10.4103/1735-1995.193503. eCollection 2016.

28.

Removing the specimen with traction during robotic radical prostatectomy does not cause a positive surgical margin.

Altınova S, İşgören AE, Akbulut Z, Özcan MF, Canda AE, Atmaca AF, Balbay MD.

Turk J Med Sci. 2016 Dec 20;46(6):1655-1657. doi: 10.3906/sag-1503-21.

PMID:
28081352
29.

Impact of robotic partial nephrectomy with and without ischemia on renal functions: experience in 34 cases.

Ener K, Canda AE, Altınova S, Atmaca AF, Alkan E, Asil E, Özcan MF, Akbulut Z, Balbay MD.

Turk J Urol. 2016 Dec;42(4):272-277.

30.

A phase I trial of the trifunctional anti Her2 × anti CD3 antibody ertumaxomab in patients with advanced solid tumors.

Haense N, Atmaca A, Pauligk C, Steinmetz K, Marmé F, Haag GM, Rieger M, Ottmann OG, Ruf P, Lindhofer H, Al-Batran SE.

BMC Cancer. 2016 Jul 7;16:420. doi: 10.1186/s12885-016-2449-0.

31.

Impact of telephonic interviews on persistence and daily adherence to insulin treatment in insulin-naïve type 2 diabetes patients: dropout study.

Yavuz DG, Bilen H, Sancak S, Garip T, Hekimsoy Z, Sahin I, Yilmaz M, Aydin H, Atmaca A, Sert M, Karakaya P, Arpaci D, Oguz A, Guvener N.

Patient Prefer Adherence. 2016 May 17;10:851-61. doi: 10.2147/PPA.S100626. eCollection 2016.

32.

Nivolumab alone and nivolumab plus ipilimumab in recurrent small-cell lung cancer (CheckMate 032): a multicentre, open-label, phase 1/2 trial.

Antonia SJ, López-Martin JA, Bendell J, Ott PA, Taylor M, Eder JP, Jäger D, Pietanza MC, Le DT, de Braud F, Morse MA, Ascierto PA, Horn L, Amin A, Pillai RN, Evans J, Chau I, Bono P, Atmaca A, Sharma P, Harbison CT, Lin CS, Christensen O, Calvo E.

Lancet Oncol. 2016 Jul;17(7):883-895. doi: 10.1016/S1470-2045(16)30098-5. Epub 2016 Jun 4. Erratum in: Lancet Oncol. 2016 Jul;17 (7):e270. Erratum in: Lancet Oncol. 2019 Feb;20(2):e70.

PMID:
27269741
33.

Early Response to Everolimus Therapy Detected on 68Ga-DOTATATE PET/CT in a Patient With Pancreatic Neuroendocrine Tumor.

Ozkan E, Soydal C, Ucak Semirgin S, Yapici O, Atmaca A, Demirag G.

Clin Nucl Med. 2016 Jul;41(7):561-3. doi: 10.1097/RLU.0000000000001242.

PMID:
27163457
34.

Malignancy rate associated with Bethesda category III (AUS/FLUS) with and without repeat fine needle aspiration biopsy.

Kuru B, Atmaca A, Kefeli M.

Diagn Cytopathol. 2016 May;44(5):394-8. doi: 10.1002/dc.23456. Epub 2016 Feb 24.

PMID:
26917413
35.

Does anterior prostatic fat tissue removed during robotic radical prostatectomy contain any lymph nodes?

Atmaca AF, Canda AE, Keske M, Arslan ME, Kamaci D, Alkan E, Balbay MD.

Cent European J Urol. 2015;68(4):410-4. doi: 10.5173/ceju.2015.650. Epub 2015 Dec 21.

36.

Robotic partial nephrectomy for clinical stage T1 tumors: Experience in 42 cases.

Ener K, Canda AE, Altinova S, Atmaca AF, Alkan E, Asil E, Ozcan MF, Akbulut Z, Balbay MD.

Kaohsiung J Med Sci. 2016 Jan;32(1):16-21. doi: 10.1016/j.kjms.2015.09.008. Epub 2015 Oct 31.

37.

Risk factors associated with malignancy and with triage to surgery in thyroid nodules classified as Bethesda category III (AUS/FLUS).

Kuru B, Atmaca A, Tarim IA, Kefeli M, Topgul K, Yoruker S, Elmali M, Danaci M.

Eur J Surg Oncol. 2016 Jan;42(1):87-93. doi: 10.1016/j.ejso.2015.09.026. Epub 2015 Oct 19.

PMID:
26527545
38.

Robotic sequential right adrenalectomy and zero ischemia left partial nephrectomy in a patient with synchronous pheochromocytoma and renal cell carcinoma.

Canda AE, Çakıcı ÖU, Ener K, Atmaca AF.

Turk J Urol. 2015 Sep;41(3):159-63. doi: 10.5152/tud.2015.21298. Epub 2015 Feb 18.

39.

Outcomes of robot-assisted laparoscopic transperitoneal pyeloplasty procedures: a series of 18 patients.

Ener K, Altınova S, Canda AE, Özcan MF, Asil E, Ürer E, Atmaca AF, Akbulut Z.

Turk J Urol. 2014 Dec;40(4):193-8. doi: 10.5152/tud.2014.33898.

40.

[Estrogen Receptors and their Impact for Prognosis and Therapy of Lung Cancer - New Insights to an Underestimated Mechanism].

Brückl WM, Al-Batran SE, Ficker JH, Wirtz RM, Atmaca A.

Pneumologie. 2015 Jun;69(6):350-60. doi: 10.1055/s-0034-1392081. Epub 2015 Jun 11. Review. German.

41.

SNAI2/SLUG and estrogen receptor mRNA expression are inversely correlated and prognostic of patient outcome in metastatic non-small cell lung cancer.

Atmaca A, Wirtz RW, Werner D, Steinmetz K, Claas S, Brueckl WM, Jäger E, Al-Batran SE.

BMC Cancer. 2015 Apr 17;15:300. doi: 10.1186/s12885-015-1310-1.

42.

Open versus robotic radical cystectomy with intracorporeal Studer diversion.

Atmaca AF, Canda AE, Gok B, Akbulut Z, Altinova S, Balbay MD.

JSLS. 2015 Jan-Mar;19(1):e2014.00193. doi: 10.4293/JSLS.2014.00193.

43.

Does diabetes affect the distribution and number of interstitial cells and neuronal tissue in the ureter, bladder, prostate, and urethra of humans?

Canda AE, Dogan H, Kandemir O, Atmaca AF, Akbulut Z, Balbay MD.

Cent European J Urol. 2014;67(4):366-74. doi: 10.5173/ceju.2014.04.art10. Epub 2014 Dec 5.

44.

What is the best radiological method to predict the actual weight of the prostate?

Kiliç M, Ozdemir AT, Altinova S, Atmaca AF, Canda AE, Balbay MD.

Turk J Med Sci. 2014;44(1):31-5.

PMID:
25558555
45.

Afatinib with concurrent radiotherapy in a patient with metastatic non-small cell lung cancer.

Atmaca A, Al-Batran SE, Allgäuer M, Jäger E.

Oncol Res Treat. 2014;37(5):262-5. doi: 10.1159/000362488. Epub 2014 Apr 14.

PMID:
24853786
46.

Long-term complete remission following radiosurgery and immunotherapy in a melanoma patient with brain metastasis: immunologic correlates.

Karbach J, Gnjatic S, Biskamp M, Atmaca A, Weidmann E, Brandt K, Wahle C, Bernhard H, Knuth A, Jäger E.

Cancer Immunol Res. 2014 May;2(5):404-9. doi: 10.1158/2326-6066.CIR-13-0200. Epub 2014 Feb 5.

47.

The validation of estrogen receptor 1 mRNA expression as a predictor of outcome in patients with metastatic non-small cell lung cancer.

Atmaca A, Al-Batran SE, Wirtz RM, Werner D, Zirlik S, Wiest G, Eschbach C, Claas S, Hartmann A, Ficker JH, Jäger E, Brueckl WM.

Int J Cancer. 2014 May 15;134(10):2314-21. doi: 10.1002/ijc.28571. Epub 2013 Nov 14.

50.

Phase I study of everolimus and mitomycin C for patients with metastatic esophagogastric adenocarcinoma.

Werner D, Atmaca A, Pauligk C, Pustowka A, Jäger E, Al-Batran SE.

Cancer Med. 2013 Jun;2(3):325-33. doi: 10.1002/cam4.77. Epub 2013 Apr 2.

Supplemental Content

Loading ...
Support Center